Order Article Reprints

Broekaart DWM, Zimmer TS, Cohen ST, Tessers R, Anink JJ, de Vries HE, Gorter JA, Prades R, Aronica E, van Vliet EA. The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity In Vitro. Biomedicines. 2022; 10(9):2117. https://doi.org/10.3390/biomedicines10092117

Broekaart, Diede W. M., Till S. Zimmer, Sophie T. Cohen, Rianne Tessers, Jasper J. Anink, Helga E. de Vries, Jan A. Gorter, Roger Prades, Eleonora Aronica, and Erwin A. van Vliet. 2022. "The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity In Vitro" Biomedicines 10, no. 9: 2117. https://doi.org/10.3390/biomedicines10092117

Broekaart, D. W. M., Zimmer, T. S., Cohen, S. T., Tessers, R., Anink, J. J., de Vries, H. E., Gorter, J. A., Prades, R., Aronica, E., & van Vliet, E. A. (2022). The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity In Vitro. Biomedicines, 10(9), 2117. https://doi.org/10.3390/biomedicines10092117